During the last session, Akebia Therapeutics Inc. (NASDAQ:AKBA)’s traded shares were 1.54 million, with the beta value of the company hitting 0.91. The 52-week high for the AKBA share is $2.48, that puts it down -81.02 from that peak though still a striking 52.55% gain since the share price plummeted to a 52-week low of $0.65. The company’s market capitalization is $286.84M, and the average trade volume was 4.81 million shares over the past three months.
Akebia Therapeutics Inc. (NASDAQ:AKBA) trade information
The stock’s 5-day price performance is -1.44%, and it has moved by -38.01% in 30 days. Based on these gigs, the overall price performance for the year is 104.26%.
Akebia Therapeutics Inc. (AKBA) estimates and forecasts
Statistics show that Akebia Therapeutics Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Akebia Therapeutics Inc. (AKBA) shares have gone up 63.15% during the last six months, with a year-to-date growth rate less than the industry average at 0.00% against 10.20. In the rating firms’ projections, revenue will decrease -2.80% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 46.34M as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 49.51M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 40.13M and 56.38M respectively. In this case, analysts expect current quarter sales to grow by 15.50% and then drop by -12.20% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 35.46%. While earnings are projected to return 0.32% in 2024.
AKBA Dividends
Akebia Therapeutics Inc. is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
